vimarsana.com
Home
Live Updates
Antiplatelet Therapy Now Standard - Breaking News
Pages:
Antiplatelet Therapy Now Standard News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Thrombolysis Not Necessary in Mild Nondisabling Stroke: ARAMIS
Dual antiplatelet treatment was noninferior to thrombolysis with regard to functional outcome at 90 days for Chinese patients with minor nondisabling stroke.
Cherry hill
New jersey
United states
University of cincinnati
Tudor jovin
Pooja khatri
Thanh nguyen
National institutes of health stroke scale
International stroke conference
Boston medical center
Cooper neurological institute
American heart association stroke
Among chinese
Medscape cardiology
National institutes
Health stroke scale
vimarsana © 2020. All Rights Reserved.